drugset / Trial / NCT00965926

A Study to Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly Volunteers

NCT00965926

Phase 1 Completed 72 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The purpose of the study is to evaluate the effect of food intake on the pharmacokinetics of YM178 in healthy, non-elderly adult subjects.

Timeline

Start
2009-07
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirabegron Other / unclassified Oral

Indications

No indication recorded.